<VariationArchive VariationID="635454" VariationName="NM_003647.3(DGKE):c.610dup (p.Thr204fs)" VariationType="Duplication" Accession="VCV000635454" Version="6" RecordType="classified" NumberOfSubmissions="4" NumberOfSubmitters="4" DateLastUpdated="2024-02-20" DateCreated="2019-07-14" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="623349" VariationID="635454">
      <GeneList>
        <Gene Symbol="DGKE" FullName="diacylglycerol kinase epsilon" GeneID="8526" HGNC_ID="HGNC:2852" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>17q22</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="56834151" stop="56869567" display_start="56834151" display_stop="56869567" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="54911459" stop="54946035" display_start="54911459" display_stop="54946035" Strand="+" />
          </Location>
          <OMIM>601440</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_003647.3(DGKE):c.610dup (p.Thr204fs)</Name>
      <CanonicalSPDI>NC_000017.11:56844157:AAAAAAA:AAAAAAAA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>17q22</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="56844157" stop="56844158" display_start="56844157" display_stop="56844158" variantLength="1" positionVCF="56844157" referenceAlleleVCF="C" alternateAlleleVCF="CA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="54921518" stop="54921519" display_start="54921518" display_stop="54921519" variantLength="1" positionVCF="54921518" referenceAlleleVCF="C" alternateAlleleVCF="CA" />
      </Location>
      <ProteinChange>T204fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.10" sequenceAccession="NC_000017" sequenceVersion="10" change="g.54921525dup" Assembly="GRCh37">
            <Expression>NC_000017.10:g.54921525dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.11" sequenceAccession="NC_000017" sequenceVersion="11" change="g.56844164dup" Assembly="GRCh38">
            <Expression>NC_000017.11:g.56844164dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_033888.1" sequenceAccession="NG_033888" sequenceVersion="1" change="g.15066dup">
            <Expression>NG_033888.1:g.15066dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003647.3" sequenceAccession="NM_003647" sequenceVersion="3" change="c.610dup" MANESelect="true">
            <Expression>NM_003647.3:c.610dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_003638.1" sequenceAccession="NP_003638" sequenceVersion="1" change="p.Thr204fs">
            <Expression>NP_003638.1:p.Thr204fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003647.2" sequenceAccession="NM_003647" sequenceVersion="2" change="c.610dupA">
            <Expression>NM_003647.2:c.610dupA</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="147972030" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_003647.3(DGKE):c.610dup (p.Thr204fs) AND Immunoglobulin-mediated membranoproliferative glomerulonephritis" Accession="RCV000786909" Version="3">
        <ClassifiedConditionList TraitSetID="9121">
          <ClassifiedCondition DB="MedGen" ID="C3554330">Immunoglobulin-mediated membranoproliferative glomerulonephritis</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-05-05" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_003647.3(DGKE):c.610dup (p.Thr204fs) AND Atypical hemolytic-uremic syndrome" Accession="RCV002294380" Version="2">
        <ClassifiedConditionList TraitSetID="7947">
          <ClassifiedCondition DB="MedGen" ID="C2931788">Atypical hemolytic-uremic syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-07-04" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_003647.3(DGKE):c.610dup (p.Thr204fs) AND not provided" Accession="RCV003558591" Version="1">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-02-08" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-02-08" NumberOfSubmissions="4" NumberOfSubmitters="4" DateCreated="2019-07-14" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">23274426</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23542698</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25443527</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">28526779</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="9121" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17531" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">NEPHROTIC SYNDROME, TYPE 7, WITH MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS</ElementValue>
                <XRef Type="MIM" ID="615008" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Nephrotic syndrome, type 7</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Immunoglobulin-mediated membranoproliferative glomerulonephritis</ElementValue>
                <XRef ID="MONDO:0014005" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">NPHS7</ElementValue>
                <XRef Type="MIM" ID="615008" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">C3 glomerulopathy (C3G) is a complex ultra-rare complement-mediated renal disease caused by uncontrolled activation of the complement alternative pathway (AP) in the fluid phase (as opposed to cell surface) that is rarely inherited in a simple mendelian fashion. C3G affects individuals of all ages, with a median age at diagnosis of 23 years. Individuals with C3G typically present with hematuria, proteinuria, hematuria and proteinuria, acute nephritic syndrome or nephrotic syndrome, and low levels of the complement component C3. Spontaneous remission of C3G is uncommon, and about half of affected individuals develop end-stage renal disease (ESRD) within ten years of diagnosis, occasionally developing the late comorbidity of impaired visual acuity.</Attribute>
                <XRef ID="NBK1425" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301598</ID>
                <ID Source="BookShelf">NBK1425</ID>
              </Citation>
              <XRef ID="329903" DB="Orphanet" />
              <XRef ID="C3554330" DB="MedGen" />
              <XRef ID="MONDO:0014005" DB="MONDO" />
              <XRef Type="MIM" ID="615008" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="7947" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="9459" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Atypical HUS</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Atypical hemolytic-uremic syndrome</ElementValue>
                <XRef ID="MONDO:0016244" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">AHUS</ElementValue>
                <XRef ID="GTR000515140" DB="Genetic Testing Registry (GTR)" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">D-HUS</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="8702" />
                <XRef ID="8702" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Hemolytic-uremic syndrome (HUS) is characterized by hemolytic anemia, thrombocytopenia, and renal failure caused by platelet thrombi in the microcirculation of the kidney and other organs. The onset of atypical HUS (aHUS) ranges from the neonatal period to adulthood. Genetic aHUS accounts for an estimated 60% of all aHUS. Individuals with genetic aHUS frequently experience relapse even after complete recovery following the presenting episode; 60% of genetic aHUS progresses to end-stage renal disease (ESRD).</Attribute>
                <XRef ID="NBK1367" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301541</ID>
                <ID Source="BookShelf">NBK1367</ID>
              </Citation>
              <Citation Type="review" Abbrev="NEJM, 2009">
                <ID Source="PubMed">19846853</ID>
              </Citation>
              <Citation Type="general" Abbrev="Brit Cmt Stand Hematol/BTS, 2010">
                <ID Source="PubMed">19821824</ID>
              </Citation>
              <XRef ID="2134" DB="Orphanet" />
              <XRef ID="C2931788" DB="MedGen" />
              <XRef ID="MONDO:0016244" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1810992" SubmissionDate="2019-03-13" DateLastUpdated="2019-07-14" DateCreated="2019-07-14">
        <ClinVarSubmissionID localKey="NM_003647.2:c.610dup|OMIM:615008" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000925810" DateUpdated="2019-07-14" DateCreated="2019-07-14" Type="SCV" Version="1" SubmitterName="Bioscientia Institut fuer Medizinische Diagnostik GmbH, Sonic Healthcare" OrgID="505827" OrganizationCategory="laboratory" OrgAbbreviation="Bioscientia" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-12-03">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="DGKE" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_003647.2:c.610dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="615008" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>BiSub20190313</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5056192" SubmissionDate="2022-10-28" DateLastUpdated="2022-10-29" DateCreated="2022-10-29">
        <ClinVarSubmissionID localKey="2022-07161|MONDO:0016244" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002587691" DateUpdated="2022-10-29" DateCreated="2022-10-29" Type="SCV" Version="1" SubmitterName="Genome Diagnostics Laboratory, The Hospital for Sick Children" OrgID="1043" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-07-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="DGKE" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_003647.2:c.610dupA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0016244" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12206080</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5435133" SubmissionDate="2022-12-13" DateLastUpdated="2022-12-31" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="NM_003647.3:c.610dup|OMIM:615008" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002776671" DateUpdated="2022-12-31" DateCreated="2022-12-31" Type="SCV" Version="1" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-05-05">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_003647.3:c.610dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="615008" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12390657</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7983134" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2024-02-14">
        <ClinVarSubmissionID localKey="4944657|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004297488" DateUpdated="2024-02-14" DateCreated="2024-02-14" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-02-08">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">23274426</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23542698</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25443527</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">28526779</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Thr204Asnfs*4) in the DGKE gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DGKE are known to be pathogenic (PMID: 23274426, 23542698). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This premature translational stop signal has been observed in individual(s) with DGKE-related conditions (PMID: 25443527, 28526779). This variant is also known as c.790_791insA. ClinVar contains an entry for this variant (Variation ID: 635454). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="DGKE" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000017.10:g.54921518_54921519insA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5435133" TraitType="Disease" MappingType="XRef" MappingValue="615008" MappingRef="OMIM">
        <MedGen CUI="C3554330" Name="Immunoglobulin-mediated membranoproliferative glomerulonephritis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5056192" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0016244" MappingRef="MONDO">
        <MedGen CUI="C2931788" Name="Atypical hemolytic-uremic syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1810992" TraitType="Disease" MappingType="XRef" MappingValue="615008" MappingRef="OMIM">
        <MedGen CUI="C3554330" Name="Immunoglobulin-mediated membranoproliferative glomerulonephritis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7983134" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

